Clinical evaluation and hepatic laboratory assessment in individuals with congestive heart failure;Avaliação clínica e laboratorial hepática em indivíduos com insuficiência cardíaca congestiva

Arquivos Brasileiros de Cardiologia

Volumn 88, Issue 5, 2007, Pages 590-595

  Vasconcelos, Luiz Antônio Brito Arruda ^a,b   De Almeida, Eros Antônio ^a   Bachur, Luiz Felipe ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Clinical evolution; Congestive heart failure; Liver; Liver function tests

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL EVALUATION; CONGESTIVE HEART FAILURE; DATA ANALYSIS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; STATISTICAL ANALYSIS; TERTIARY HEALTH CARE;

EID: 34347346230     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2007000500015     Document Type: Article

References (15)

1. Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J. 2000;1:140.
2. Ridruejo E, Laurini J, Cingolani O. Fulminant hepatic failure. Atypical form of cardiac failure presentation. Medicina (B. Aires). 2000;4(60):491-4.
3. Bailey RW, Brengman ML, Fuh KC, Hamilton SR, Herlong HF, Bulkley GB. Hemodynamic pathogenesis of ischemic hepatic injury following cardiogenic shock/resuscitation. Shock. 2000;4(14):451-9.
4. Vilas-Boas F, Monachini MC, Farias A, Kopel L, Lage SG, Pileggi F. Acute liver failure secondary to cardiogenic shock in patients with congestive heart failure. Arq Bras Cardiol. 1994;6(62):427-30.
5. Rodriguez-Artalejo F, Banegas Banegas JR, Guallar-Castillon P. Epidemiology of heart failure. Rev Esp Cardiol. 2004;57(2):161-2.
6. Cox RA, Torres CZ. Acute heart failure in adults. P R Health Sci J. 2004;23(4):265-71.
7. Kay JD, Colan SD, Graham TP. Congestive heart failure in pediatric patients. Am Heart J. 2001;142(5):923-7.
8. Biondi-Zoccai GG, Baldi A, Biasucci LM, Abbate A. Female gender, myocardial remodeling and cardiac failure: are women protected from increased myocardiocyte apoptosis? Ital Heart J. 2004;5(7):498-504.
9. Lund LH, Mancini D. Heart failure in women. Med Clin North Am. 2004;88(5):1321-45.
10. Regitz-Zagrosek V. Cardiovascular disease in postmenopausal women. Climacteric. 2003;6(3):13-20.
11. Tendera M. The epidemiology of heart failure. J Renin Angiotensin Aldosterone Syst. 2004;5(Suppl 1): S2-6.
12. Mesquita ET. Heart failure in Brazil. The EPICA-Niteroi study. Rev Port Cardiol. 2004;23(3):25-30.
13. Kubo SH, Walter BA, John DH, Clark M, Cody RJ. Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med. 1987;147(7):1227-30.
14. Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol. 2002;90:1405-9.
15. Cogger VC, Fraser R, LeCouteur DG. Liver dysfunction and heart failure. Am J Cardiol. 2003;91:1399.